Eric Floyd serves as Executive at Virpax Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Eric Floyd has executed 1 insider transactions totaling $6.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 18, 2022 involved purchasing 4,479 shares valued at $6.1K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 18, 2022 | VRPX | $6.1K | Purchase | 4,479 | $1.36 | Discretionary |
Eric Floyd currently holds 8,018 shares of Virpax Pharmaceuticals, Inc. (VRPX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Floyd has been a net buyer of VRPX stock. They have purchased $6.1K and sold $0 worth of shares.
Eric Floyd's most recent insider trade was on May 18, 2022, when they purchased 4,479 shares at $1.36 per share.
Get notified when new Form 4 filings are submitted